Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Monday 19 October 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

R&D

Depressed woman looks out rain spattered window in city

Removing barriers in treatment-resistant depression

pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.

R&D

Hospital corridor with HCPs

Hospital financial pressure is reshaping how we think about ...

Health systems face the pressure of maintaining continuity of care in an environment where supply disruptions and drug shortages persist as concerns.

Digital

Data analytics and batch release

Better analytics leads to fewer regulator questions

Stronger data analytics is cutting the number of questions regulators ask about intensified processes.

R&D

Boosting biotech in Basel – with Valentina Francia

Boosting biotech in Basel – with Valentina Francia

pharmaphorum speaks with Valentina Francia from Basel Area Business and Innovation about why many life sciences startups are finding success in Basel.

Sales & Marketing

Hiring of investor at meeting, men and women

Changing Faces: Agency, consultancy, and investor hires, Aug...

August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.

Articles

Early stage funding: how to improve odds of success

Early stage funding: how to improve odds of success

In this new serial of articles, Jean-Louis Roux Dit Buisson shares with us his experience in selecting projects for future investments and proposes solutions to improve odds of success in early

Articles

mHealth: Empowering patients through mobile health innovation

mHealth: Empowering patients through mobile health innovatio...

In the digital age, mobile healthcare (mHealth) is being hyped by many commentators as 'the next big thing' with the potential to transform global healthcare.

Articles

KOL perspectives: Dr Sudeep Srivastava on vaccine manufacturing trends in India

KOL perspectives: Dr Sudeep Srivastava on vaccine manufactur...

Syamala Ariyanchira interviews Dr Sudeep Srivastava about the vaccine manufacturing trends in India for our latest KOL perspectives article.

Load more results

Sales & Marketing

Sales & Marketing

Hiring of investor at meeting, men and women

Changing Faces: Agency, consultancy, and investor hires, Aug...

August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.

Sales & Marketing

Klick Health and Oxford PharmaGenesis

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Digital

Digital

Data analytics and batch release

Better analytics leads to fewer regulator questions

Stronger data analytics is cutting the number of questions regulators ask about intensified processes.

Digital

pharmaphorum podcast Episode 280, Robbie Tyrie, Torridon Cyber

AI governance & cybersecurity: Torridon Cyber’s Robbie Tyrie

Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.

Market Access

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Editor's Picks

CHMP backs Lilly's oral GLP-1 Foundayo for EU approval

RevMed nears EU okay for pancreatic cancer drug Rasonque

Roche adds another obesity drug with $1.16bn Rona deal

MHRA lays out its thinking on AI and medicines regulation

GSK planning 1,200 job cuts in Belgium, says paper

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Dr Michael Bauer and Jonah Comstock

Dr Michael Bauer on Quantro’s mission to drug the “undruggab...

Jonah Comstock reunited with Dr Michael Bauer, CEO of Quantro Therapeutics, at LSX 2026 to discuss the company's progress.

Oncology

Cancer cell and T-cells

In vivo CAR-T can solve the delivery problem – but solid tum...

A new generation of in vivo CAR-T cell technologies promises to remove some of the biggest practical barriers to conventional cell therapy.

Oncology

T-cells in action

Unlocking the scalability of allogeneic CAR-T

Allogeneic CAR-T, built from healthy donor T-cells, offers a different path toward scale, accessibility, and consistency.

Patients

Patients

female HCP confers with female patient

From bedside to breakthroughs: Reimagining the human experie...

Patients should be involved in the programme design process from the beginning, as co-creators with full influence over the outcome.

Patients

Hispanic heritage

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Patients

World Sight Day

Durability and earlier access could reshape diabetic retinop...

This year’s World Sight Day turns global attention to the scale of preventable vision loss

R&D

R&D

Depressed woman looks out rain spattered window in city

Removing barriers in treatment-resistant depression

pharmaphorum speaks with Hans Eriksson, psychiatrist and CMO of FundaMental Pharma, about why treatment resistance remains such a challenge.

R&D

Hospital corridor with HCPs

Hospital financial pressure is reshaping how we think about ...

Health systems face the pressure of maintaining continuity of care in an environment where supply disruptions and drug shortages persist as concerns.

R&D

Boosting biotech in Basel – with Valentina Francia

Boosting biotech in Basel – with Valentina Francia

pharmaphorum speaks with Valentina Francia from Basel Area Business and Innovation about why many life sciences startups are finding success in Basel.

Editor's Picks

CHMP backs Lilly's oral GLP-1 Foundayo for EU approval

RevMed nears EU okay for pancreatic cancer drug Rasonque

Roche adds another obesity drug with $1.16bn Rona deal

MHRA lays out its thinking on AI and medicines regulation

GSK planning 1,200 job cuts in Belgium, says paper

News

Novartis abandons Fabhalta trial in lupus nephritis

Novartis abandons Fabhalta trial in lupus nephritis

A failed phase 2 study has undermined Novartis' hopes of extending the approved indications for Fabhalta to include lupus nephritis.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company